Amber Koehler, MPAS, PA-C, on Tolerability and Progression-Free Survival of Nivolumab-AVD in Advanced Stage Hodgkin Lymphoma

Amber Koehler, MPAS, PA-C, of Mayo Clinic, reports on the favorable outcomes and better tolerability of nivolumab (N) with doxorubicin, vinblastine, and dacarbazine (AVD) compared with brentuximab vedotin (BV) with AVD in patients with newly diagnosed advanced stage Hodgkin Lymphoma (Abstract 181).